000 | 01976 a2200541 4500 | ||
---|---|---|---|
005 | 20250516024917.0 | ||
264 | 0 | _c20110819 | |
008 | 201108s 0 0 eng d | ||
022 | _a1552-5783 | ||
024 | 7 |
_a10.1167/iovs.10-6588 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCampa, Claudio | |
245 | 0 | 0 |
_aEarly multifocal electroretinogram findings during intravitreal ranibizumab treatment for neovascular age-related macular degeneration. _h[electronic resource] |
260 |
_bInvestigative ophthalmology & visual science _cJun 2011 |
||
300 |
_a3446-51 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAngiogenesis Inhibitors _xadministration & dosage |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
650 | 0 | 4 | _aColoring Agents |
650 | 0 | 4 |
_aContrast Sensitivity _xphysiology |
650 | 0 | 4 |
_aElectroretinography _xdrug effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFluorescein Angiography |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIndocyanine Green |
650 | 0 | 4 | _aIntravitreal Injections |
650 | 0 | 4 | _aLongitudinal Studies |
650 | 0 | 4 |
_aMacular Degeneration _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aRanibizumab |
650 | 0 | 4 |
_aRetina _xphysiopathology |
650 | 0 | 4 | _aTomography, Optical Coherence |
650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xantagonists & inhibitors |
650 | 0 | 4 |
_aVisual Acuity _xphysiology |
700 | 1 | _aHagan, Richard | |
700 | 1 | _aSahni, Jayashree N | |
700 | 1 | _aBrown, Malcolm C | |
700 | 1 | _aBeare, Nicholas A V | |
700 | 1 | _aHeimann, Heinrich | |
700 | 1 | _aHarding, Simon P | |
773 | 0 |
_tInvestigative ophthalmology & visual science _gvol. 52 _gno. 6 _gp. 3446-51 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1167/iovs.10-6588 _zAvailable from publisher's website |
999 |
_c20632338 _d20632338 |